Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis
NCT02166021
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis (MS)
Interventions
BIOLOGICAL:
Mesenchymal stem cells
Sponsor
Dimitrios Karussis